Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2025 | Assessing the incidence of bladder cancer during the COVID-19 pandemic

Alessandro Bertini • 28 Feb 2025
EAU 2025
Bladder Cancer Genitourinary Cancer

Alessandro Bertini, MD, Henry Ford Health System, Detroit, MI, comments on the impact of the COVID-19 pandemic on bladder cancer incidence. While many retrospective studies analysed patients diagnosed with bladder cancer, Dr Bertini analysed disease incidence, which observed a lower incidence of disease; findings were in line with related studies. Although mortality was not assessed, a lack of correlation here is hypothesised. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Alessandro Bertini

Perioperative outcomes of single- versus multi-port robotic prostatectomy
1:49
Perioperative outcomes of single- versus multi-port robotic prostatectomy
Alessandro Bertini • 28 Feb 2025
Long-term outcomes of PSA persistence after robotic prostatectomy
1:49
Long-term outcomes of PSA persistence after robotic prostatectomy
Alessandro Bertini • 28 Feb 2025
The impact of socioeconomic deprivation in oncological outcomes
2:23
The impact of socioeconomic deprivation in oncological outcomes
Alessandro Bertini • 28 Feb 2025
Socioeconomic disparities in quality of surgery in patients with MIBC
2:57
Socioeconomic disparities in quality of surgery in patients with MIBC
Alessandro Bertini • 28 Feb 2025

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals